Global Injectable Seizure Drugs Supply, Demand and Key Producers, 2024-2030
Page: 120
Published Date: 14 Feb 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Injectable Seizure Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Injectable Seizure Drugs Market Segmented By Drug Type such as Fosphenytoin, Midazolam, Carbamazepine, Cenobamate, Gabapentin, Phenytoin, Lamotrigine, Topiramate, Levetiracetam, Clobazam, Diazepam having Therapy such as Monotherapy and Combination Therapy
This report studies the global Injectable Seizure Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Injectable Seizure Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Injectable Seizure Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Injectable Seizure Drugs total production and demand, 2019-2030, (K Units)
Global Injectable Seizure Drugs total production value, 2019-2030, (USD Million)
Global Injectable Seizure Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Injectable Seizure Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Injectable Seizure Drugs domestic production, consumption, key domestic manufacturers and share
Global Injectable Seizure Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Injectable Seizure Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Injectable Seizure Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Injectable Seizure Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., GW Pharmaceuticals plc, UCB S.A., Eisai Co.Ltd., Sunovion Pharmaceuticals Inc., H. Lundbeck A/S, GlaxoSmithKline plc, Sandoz Inc. and Omega Laboratories Ltd ERFA Canada 2012 Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Injectable Seizure Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Injectable Seizure Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Injectable Seizure Drugs Market, Segmentation by Type
Fosphenytoin
Midazolam
Carbamazepine
Cenobamate
Gabapentin
Phenytoin
Lamotrigine
Topiramate
Levetiracetam
Others
Global Injectable Seizure Drugs Market, Segmentation by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Companies Profiled:
Pfizer Inc.
GW Pharmaceuticals plc
UCB S.A.
Eisai Co.Ltd.
Sunovion Pharmaceuticals Inc.
H. Lundbeck A/S
GlaxoSmithKline plc
Sandoz Inc.
Omega Laboratories Ltd ERFA Canada 2012 Inc.
Lundbeck Pharmaceuticals Llc
Fresenius Kabi
Mylan Pharmaceuticals
Hoffmann La and
Key Questions Answered
1. How big is the global Injectable Seizure Drugs market?
2. What is the demand of the global Injectable Seizure Drugs market?
3. What is the year over year growth of the global Injectable Seizure Drugs market?
4. What is the production and production value of the global Injectable Seizure Drugs market?
5. Who are the key producers in the global Injectable Seizure Drugs market?
Table of Contents
1 Supply Summary
1.1 Injectable Seizure Drugs Introduction
1.2 World Injectable Seizure Drugs Supply & Forecast
1.2.1 World Injectable Seizure Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Injectable Seizure Drugs Production (2019-2030)
1.2.3 World Injectable Seizure Drugs Pricing Trends (2019-2030)
1.3 World Injectable Seizure Drugs Production by Region (Based on Production Site)
1.3.1 World Injectable Seizure Drugs Production Value by Region (2019-2030)
1.3.2 World Injectable Seizure Drugs Production by Region (2019-2030)
1.3.3 World Injectable Seizure Drugs Average Price by Region (2019-2030)
1.3.4 North America Injectable Seizure Drugs Production (2019-2030)
1.3.5 Europe Injectable Seizure Drugs Production (2019-2030)
1.3.6 China Injectable Seizure Drugs Production (2019-2030)
1.3.7 Japan Injectable Seizure Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Injectable Seizure Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Injectable Seizure Drugs Major Market Trends
2.1 World Injectable Seizure Drugs Demand (2019-2030)
2.2 World Injectable Seizure Drugs Consumption by Region
2.2.1 World Injectable Seizure Drugs Consumption by Region (2019-2024)
2.2.2 World Injectable Seizure Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Injectable Seizure Drugs Consumption (2019-2030)
2.4 China Injectable Seizure Drugs Consumption (2019-2030)
2.5 Europe Injectable Seizure Drugs Consumption (2019-2030)
2.6 Japan Injectable Seizure Drugs Consumption (2019-2030)
2.7 South Korea Injectable Seizure Drugs Consumption (2019-2030)
2.8 ASEAN Injectable Seizure Drugs Consumption (2019-2030)
2.9 India Injectable Seizure Drugs Consumption (2019-2030)
3.1 World Injectable Seizure Drugs Production Value by Manufacturer (2019-2024)
3.2 World Injectable Seizure Drugs Production by Manufacturer (2019-2024)
3.3 World Injectable Seizure Drugs Average Price by Manufacturer (2019-2024)
3.4 Injectable Seizure Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Injectable Seizure Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Injectable Seizure Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Injectable Seizure Drugs in 2023
3.6 Injectable Seizure Drugs Market: Overall Company Footprint Analysis
3.6.1 Injectable Seizure Drugs Market: Region Footprint
3.6.2 Injectable Seizure Drugs Market: Company Product Type Footprint
3.6.3 Injectable Seizure Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Injectable Seizure Drugs Production Value Comparison
4.1.1 United States VS China: Injectable Seizure Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Injectable Seizure Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Injectable Seizure Drugs Production Comparison
4.2.1 United States VS China: Injectable Seizure Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Injectable Seizure Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Injectable Seizure Drugs Consumption Comparison
4.3.1 United States VS China: Injectable Seizure Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Injectable Seizure Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Injectable Seizure Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Injectable Seizure Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Injectable Seizure Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Injectable Seizure Drugs Production (2019-2024)
4.5 China Based Injectable Seizure Drugs Manufacturers and Market Share
4.5.1 China Based Injectable Seizure Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Injectable Seizure Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Injectable Seizure Drugs Production (2019-2024)
4.6 Rest of World Based Injectable Seizure Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Injectable Seizure Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Injectable Seizure Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Injectable Seizure Drugs Production (2019-2024)
5.1 World Injectable Seizure Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Fosphenytoin
5.2.2 Midazolam
5.2.3 Carbamazepine
5.2.4 Cenobamate
5.2.5 Gabapentin
5.2.6 Phenytoin
5.2.7 Lamotrigine
5.2.8 Topiramate
5.2.9 Levetiracetam
5.2.10 Others
5.3 Market Segment by Type
5.3.1 World Injectable Seizure Drugs Production by Type (2019-2030)
5.3.2 World Injectable Seizure Drugs Production Value by Type (2019-2030)
5.3.3 World Injectable Seizure Drugs Average Price by Type (2019-2030)
6.1 World Injectable Seizure Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Injectable Seizure Drugs Production by Application (2019-2030)
6.3.2 World Injectable Seizure Drugs Production Value by Application (2019-2030)
6.3.3 World Injectable Seizure Drugs Average Price by Application (2019-2030)
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Details
7.1.2 Pfizer Inc. Major Business
7.1.3 Pfizer Inc. Injectable Seizure Drugs Product and Services
7.1.4 Pfizer Inc. Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Pfizer Inc. Recent Developments/Updates
7.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.2 GW Pharmaceuticals plc
7.2.1 GW Pharmaceuticals plc Details
7.2.2 GW Pharmaceuticals plc Major Business
7.2.3 GW Pharmaceuticals plc Injectable Seizure Drugs Product and Services
7.2.4 GW Pharmaceuticals plc Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 GW Pharmaceuticals plc Recent Developments/Updates
7.2.6 GW Pharmaceuticals plc Competitive Strengths & Weaknesses
7.3 UCB S.A.
7.3.1 UCB S.A. Details
7.3.2 UCB S.A. Major Business
7.3.3 UCB S.A. Injectable Seizure Drugs Product and Services
7.3.4 UCB S.A. Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 UCB S.A. Recent Developments/Updates
7.3.6 UCB S.A. Competitive Strengths & Weaknesses
7.4 Eisai Co.Ltd.
7.4.1 Eisai Co.Ltd. Details
7.4.2 Eisai Co.Ltd. Major Business
7.4.3 Eisai Co.Ltd. Injectable Seizure Drugs Product and Services
7.4.4 Eisai Co.Ltd. Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Eisai Co.Ltd. Recent Developments/Updates
7.4.6 Eisai Co.Ltd. Competitive Strengths & Weaknesses
7.5 Sunovion Pharmaceuticals Inc.
7.5.1 Sunovion Pharmaceuticals Inc. Details
7.5.2 Sunovion Pharmaceuticals Inc. Major Business
7.5.3 Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Product and Services
7.5.4 Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Sunovion Pharmaceuticals Inc. Recent Developments/Updates
7.5.6 Sunovion Pharmaceuticals Inc. Competitive Strengths & Weaknesses
7.6 H. Lundbeck A/S
7.6.1 H. Lundbeck A/S Details
7.6.2 H. Lundbeck A/S Major Business
7.6.3 H. Lundbeck A/S Injectable Seizure Drugs Product and Services
7.6.4 H. Lundbeck A/S Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 H. Lundbeck A/S Recent Developments/Updates
7.6.6 H. Lundbeck A/S Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Details
7.7.2 GlaxoSmithKline plc Major Business
7.7.3 GlaxoSmithKline plc Injectable Seizure Drugs Product and Services
7.7.4 GlaxoSmithKline plc Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 GlaxoSmithKline plc Recent Developments/Updates
7.7.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.8 Sandoz Inc.
7.8.1 Sandoz Inc. Details
7.8.2 Sandoz Inc. Major Business
7.8.3 Sandoz Inc. Injectable Seizure Drugs Product and Services
7.8.4 Sandoz Inc. Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Sandoz Inc. Recent Developments/Updates
7.8.6 Sandoz Inc. Competitive Strengths & Weaknesses
7.9 Omega Laboratories Ltd ERFA Canada 2012 Inc.
7.9.1 Omega Laboratories Ltd ERFA Canada 2012 Inc. Details
7.9.2 Omega Laboratories Ltd ERFA Canada 2012 Inc. Major Business
7.9.3 Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Product and Services
7.9.4 Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Omega Laboratories Ltd ERFA Canada 2012 Inc. Recent Developments/Updates
7.9.6 Omega Laboratories Ltd ERFA Canada 2012 Inc. Competitive Strengths & Weaknesses
7.10 Lundbeck Pharmaceuticals Llc
7.10.1 Lundbeck Pharmaceuticals Llc Details
7.10.2 Lundbeck Pharmaceuticals Llc Major Business
7.10.3 Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Product and Services
7.10.4 Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Lundbeck Pharmaceuticals Llc Recent Developments/Updates
7.10.6 Lundbeck Pharmaceuticals Llc Competitive Strengths & Weaknesses
7.11 Fresenius Kabi
7.11.1 Fresenius Kabi Details
7.11.2 Fresenius Kabi Major Business
7.11.3 Fresenius Kabi Injectable Seizure Drugs Product and Services
7.11.4 Fresenius Kabi Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Fresenius Kabi Recent Developments/Updates
7.11.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.12 Mylan Pharmaceuticals
7.12.1 Mylan Pharmaceuticals Details
7.12.2 Mylan Pharmaceuticals Major Business
7.12.3 Mylan Pharmaceuticals Injectable Seizure Drugs Product and Services
7.12.4 Mylan Pharmaceuticals Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Mylan Pharmaceuticals Recent Developments/Updates
7.12.6 Mylan Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Hoffmann La and
7.13.1 Hoffmann La and Details
7.13.2 Hoffmann La and Major Business
7.13.3 Hoffmann La and Injectable Seizure Drugs Product and Services
7.13.4 Hoffmann La and Injectable Seizure Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Hoffmann La and Recent Developments/Updates
7.13.6 Hoffmann La and Competitive Strengths & Weaknesses
8.1 Injectable Seizure Drugs Industry Chain
8.2 Injectable Seizure Drugs Upstream Analysis
8.2.1 Injectable Seizure Drugs Core Raw Materials
8.2.2 Main Manufacturers of Injectable Seizure Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Injectable Seizure Drugs Production Mode
8.6 Injectable Seizure Drugs Procurement Model
8.7 Injectable Seizure Drugs Industry Sales Model and Sales Channels
8.7.1 Injectable Seizure Drugs Sales Model
8.7.2 Injectable Seizure Drugs Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Injectable Seizure Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Injectable Seizure Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Injectable Seizure Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Injectable Seizure Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Injectable Seizure Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Injectable Seizure Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Injectable Seizure Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Injectable Seizure Drugs Production Market Share by Region (2019-2024)
Table 9. World Injectable Seizure Drugs Production Market Share by Region (2025-2030)
Table 10. World Injectable Seizure Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Injectable Seizure Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Injectable Seizure Drugs Major Market Trends
Table 13. World Injectable Seizure Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Injectable Seizure Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Injectable Seizure Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Injectable Seizure Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Injectable Seizure Drugs Producers in 2023
Table 18. World Injectable Seizure Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Injectable Seizure Drugs Producers in 2023
Table 20. World Injectable Seizure Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Injectable Seizure Drugs Company Evaluation Quadrant
Table 22. World Injectable Seizure Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Injectable Seizure Drugs Production Site of Key Manufacturer
Table 24. Injectable Seizure Drugs Market: Company Product Type Footprint
Table 25. Injectable Seizure Drugs Market: Company Product Application Footprint
Table 26. Injectable Seizure Drugs Competitive Factors
Table 27. Injectable Seizure Drugs New Entrant and Capacity Expansion Plans
Table 28. Injectable Seizure Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Injectable Seizure Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Injectable Seizure Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Injectable Seizure Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Injectable Seizure Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Injectable Seizure Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Injectable Seizure Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Injectable Seizure Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Injectable Seizure Drugs Production Market Share (2019-2024)
Table 37. China Based Injectable Seizure Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Injectable Seizure Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Injectable Seizure Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Injectable Seizure Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Injectable Seizure Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Injectable Seizure Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Injectable Seizure Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Injectable Seizure Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Injectable Seizure Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Injectable Seizure Drugs Production Market Share (2019-2024)
Table 47. World Injectable Seizure Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Injectable Seizure Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Injectable Seizure Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Injectable Seizure Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Injectable Seizure Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Injectable Seizure Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Injectable Seizure Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Injectable Seizure Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Injectable Seizure Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Injectable Seizure Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Injectable Seizure Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Injectable Seizure Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Injectable Seizure Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Injectable Seizure Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Inc. Major Business
Table 63. Pfizer Inc. Injectable Seizure Drugs Product and Services
Table 64. Pfizer Inc. Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Inc. Recent Developments/Updates
Table 66. Pfizer Inc. Competitive Strengths & Weaknesses
Table 67. GW Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 68. GW Pharmaceuticals plc Major Business
Table 69. GW Pharmaceuticals plc Injectable Seizure Drugs Product and Services
Table 70. GW Pharmaceuticals plc Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. GW Pharmaceuticals plc Recent Developments/Updates
Table 72. GW Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 73. UCB S.A. Basic Information, Manufacturing Base and Competitors
Table 74. UCB S.A. Major Business
Table 75. UCB S.A. Injectable Seizure Drugs Product and Services
Table 76. UCB S.A. Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. UCB S.A. Recent Developments/Updates
Table 78. UCB S.A. Competitive Strengths & Weaknesses
Table 79. Eisai Co.Ltd. Basic Information, Manufacturing Base and Competitors
Table 80. Eisai Co.Ltd. Major Business
Table 81. Eisai Co.Ltd. Injectable Seizure Drugs Product and Services
Table 82. Eisai Co.Ltd. Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Eisai Co.Ltd. Recent Developments/Updates
Table 84. Eisai Co.Ltd. Competitive Strengths & Weaknesses
Table 85. Sunovion Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Sunovion Pharmaceuticals Inc. Major Business
Table 87. Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Product and Services
Table 88. Sunovion Pharmaceuticals Inc. Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sunovion Pharmaceuticals Inc. Recent Developments/Updates
Table 90. Sunovion Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 91. H. Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 92. H. Lundbeck A/S Major Business
Table 93. H. Lundbeck A/S Injectable Seizure Drugs Product and Services
Table 94. H. Lundbeck A/S Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. H. Lundbeck A/S Recent Developments/Updates
Table 96. H. Lundbeck A/S Competitive Strengths & Weaknesses
Table 97. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 98. GlaxoSmithKline plc Major Business
Table 99. GlaxoSmithKline plc Injectable Seizure Drugs Product and Services
Table 100. GlaxoSmithKline plc Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. GlaxoSmithKline plc Recent Developments/Updates
Table 102. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 103. Sandoz Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Sandoz Inc. Major Business
Table 105. Sandoz Inc. Injectable Seizure Drugs Product and Services
Table 106. Sandoz Inc. Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Sandoz Inc. Recent Developments/Updates
Table 108. Sandoz Inc. Competitive Strengths & Weaknesses
Table 109. Omega Laboratories Ltd ERFA Canada 2012 Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Omega Laboratories Ltd ERFA Canada 2012 Inc. Major Business
Table 111. Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Product and Services
Table 112. Omega Laboratories Ltd ERFA Canada 2012 Inc. Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Omega Laboratories Ltd ERFA Canada 2012 Inc. Recent Developments/Updates
Table 114. Omega Laboratories Ltd ERFA Canada 2012 Inc. Competitive Strengths & Weaknesses
Table 115. Lundbeck Pharmaceuticals Llc Basic Information, Manufacturing Base and Competitors
Table 116. Lundbeck Pharmaceuticals Llc Major Business
Table 117. Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Product and Services
Table 118. Lundbeck Pharmaceuticals Llc Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Lundbeck Pharmaceuticals Llc Recent Developments/Updates
Table 120. Lundbeck Pharmaceuticals Llc Competitive Strengths & Weaknesses
Table 121. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 122. Fresenius Kabi Major Business
Table 123. Fresenius Kabi Injectable Seizure Drugs Product and Services
Table 124. Fresenius Kabi Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Fresenius Kabi Recent Developments/Updates
Table 126. Fresenius Kabi Competitive Strengths & Weaknesses
Table 127. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Mylan Pharmaceuticals Major Business
Table 129. Mylan Pharmaceuticals Injectable Seizure Drugs Product and Services
Table 130. Mylan Pharmaceuticals Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Mylan Pharmaceuticals Recent Developments/Updates
Table 132. Hoffmann La and Basic Information, Manufacturing Base and Competitors
Table 133. Hoffmann La and Major Business
Table 134. Hoffmann La and Injectable Seizure Drugs Product and Services
Table 135. Hoffmann La and Injectable Seizure Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 136. Global Key Players of Injectable Seizure Drugs Upstream (Raw Materials)
Table 137. Injectable Seizure Drugs Typical Customers
Table 138. Injectable Seizure Drugs Typical Distributors
List of Figure
Figure 1. Injectable Seizure Drugs Picture
Figure 2. World Injectable Seizure Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Injectable Seizure Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Injectable Seizure Drugs Production (2019-2030) & (K Units)
Figure 5. World Injectable Seizure Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Injectable Seizure Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Injectable Seizure Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Injectable Seizure Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Injectable Seizure Drugs Production (2019-2030) & (K Units)
Figure 10. China Injectable Seizure Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Injectable Seizure Drugs Production (2019-2030) & (K Units)
Figure 12. Injectable Seizure Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Injectable Seizure Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Injectable Seizure Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Injectable Seizure Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Injectable Seizure Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Injectable Seizure Drugs Markets in 2023
Figure 26. United States VS China: Injectable Seizure Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Injectable Seizure Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Injectable Seizure Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Injectable Seizure Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Injectable Seizure Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Injectable Seizure Drugs Production Market Share 2023
Figure 32. World Injectable Seizure Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Injectable Seizure Drugs Production Value Market Share by Type in 2023
Figure 34. Fosphenytoin
Figure 35. Midazolam
Figure 36. Carbamazepine
Figure 37. Cenobamate
Figure 38. Gabapentin
Figure 39. Phenytoin
Figure 40. Lamotrigine
Figure 41. Topiramate
Figure 42. Levetiracetam
Figure 43. Others
Figure 44. World Injectable Seizure Drugs Production Market Share by Type (2019-2030)
Figure 45. World Injectable Seizure Drugs Production Value Market Share by Type (2019-2030)
Figure 46. World Injectable Seizure Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 47. World Injectable Seizure Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 48. World Injectable Seizure Drugs Production Value Market Share by Application in 2023
Figure 49. Hospital Pharmacies
Figure 50. Retail Pharmacies
Figure 51. Online Pharmacies
Figure 52. Others
Figure 53. World Injectable Seizure Drugs Production Market Share by Application (2019-2030)
Figure 54. World Injectable Seizure Drugs Production Value Market Share by Application (2019-2030)
Figure 55. World Injectable Seizure Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 56. Injectable Seizure Drugs Industry Chain
Figure 57. Injectable Seizure Drugs Procurement Model
Figure 58. Injectable Seizure Drugs Sales Model
Figure 59. Injectable Seizure Drugs Sales Channels, Direct Sales, and Distribution
Figure 60. Methodology
Figure 61. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer Inc. GW Pharmaceuticals plc UCB S.A. Eisai Co.Ltd. Sunovion Pharmaceuticals Inc. H. Lundbeck A/S GlaxoSmithKline plc Sandoz Inc. Omega Laboratories Ltd ERFA Canada 2012 Inc. Lundbeck Pharmaceuticals Llc Fresenius Kabi Mylan Pharmaceuticals Hoffmann La and
Related Reports
26 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
